Anula Jayasuriya - 01 Jul 2023 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role: Director
Signature: /s/ Jonathan Wolin, Attorney-in-Fact
Issuer symbol: JAGX
Transactions as of: 01 Jul 2023
Transactions value $: $0
Form type: 4
Filing time: 14 Aug 2023, 17:55:07 UTC
Previous filing: 06 Apr 2023
Next filing: 02 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAGX	Common Stock	Award	$0	+1,718		$0	1,718	01 Jul 2023	Direct
transaction	JAGX	Common Stock	Award	$0	+68,568	+3,991%	$0	70,286	14 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAGX	Restricted stock units	Award	$0	-1,718	-100%	$0^*	0	01 Jul 2023	Common Stock	1,718		Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted pursuant to the issuer's 2014 Stock Incentive Plan (the "Plan").
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock.
F3	The RSUs vested in full on July 1, 2023, the first anniversary of the service start date. Vested shares were delivered to the reporting person on the vesting date provided in the grant notice, subject to the reporting person's continuous services through such vesting date.